focus -WSS

focus

author：Wikipedia 2025-09-30 17:44:24 - browse：46

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： New clues to why women have higher risk of autoimmune disorders

Wikipedia

WSS

Medicare drug price negotiation legal challenge met with skepticism

'A game

White House Covid adviser calls on docs to combat misinformation

People with substance use disorder deserve online privacy

The unintended consequences of overturning Roe v. Wade

Investment in vaccine development is lagging, report finds

focus

focus

explore

Moonlake's readout produced a cash windfall. Risks remain

Patients, doctors press FTC to beef up hospital merger scrutiny

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Zyn nicotine pouches become unlikely player in latest culture war

New air purifier tech could be key to improving indoor air quality

Merck, Johnson & Johnson CEOs will testify on high drug prices

Continuity nursing helped my family in our darkest PICU moments

FDA weighs limits of animal data in assessing artificial wombs

Sports medicine is finally prioritizing gender equality

Covid’s new normal has set in amid another rise in cases

leisure time

Information blocking fines are now fair game in health care

Chamber of Commerce, DOJ clash in court over drug prices

Midwives could help bridge maternal health disparities in the U.S.

Fed up with FDA, ALS advocates consider a take

Syphilis numbers in the United States reach record heights

What happened to the House vote on health price transparency?

Wikipedia

Wikipedia

leisure time

hotspot